|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-17
|
|
pubmed:abstractText |
To evaluate the therapeutic benefits by adding chemotherapy (+C) and/or accelerated-fractionation (AF) for patients with T3-4N0-1M0 nasopharyngeal carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1879-0887
|
|
pubmed:author |
pubmed-author:AuGordon K HGK,
pubmed-author:ChanAnthony T CAT,
pubmed-author:ChappellRickR,
pubmed-author:FuYiu-TungYT,
pubmed-author:FungKa-KitKK,
pubmed-author:JuusolaMM,
pubmed-author:LauWai-HonWH,
pubmed-author:LeeAnne W MAW,
pubmed-author:LeungSing-FaiSF,
pubmed-author:LeungTo-WaiTW,
pubmed-author:LuTai-XiangTX,
pubmed-author:NgWai-TongWT,
pubmed-author:O'SullivanBrianB,
pubmed-author:SiuLillianL,
pubmed-author:TanEng-HuatEH,
pubmed-author:TanTerenceT,
pubmed-author:TungRaymondR,
pubmed-author:TungStewart YSY,
pubmed-author:YauStephenS,
pubmed-author:ZhaoChongC
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
15-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20971520-Adult,
pubmed-meshheading:20971520-Aged,
pubmed-meshheading:20971520-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20971520-Chemotherapy, Adjuvant,
pubmed-meshheading:20971520-Cisplatin,
pubmed-meshheading:20971520-Combined Modality Therapy,
pubmed-meshheading:20971520-Dose Fractionation,
pubmed-meshheading:20971520-Female,
pubmed-meshheading:20971520-Fluorouracil,
pubmed-meshheading:20971520-Humans,
pubmed-meshheading:20971520-Male,
pubmed-meshheading:20971520-Middle Aged,
pubmed-meshheading:20971520-Nasopharyngeal Neoplasms,
pubmed-meshheading:20971520-Neoplasm Staging,
pubmed-meshheading:20971520-Patient Compliance
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma.
|
|
pubmed:affiliation |
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, China. awmlee@ha.org.hk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
